Search Prime Grants

U54CA243125

Cooperative Agreement

Overview

Grant Description
Biology and therapy of C11ORF95-RELA fusion-driven ependymoma
Awardee
Fred Hutchinson Cancer Center
Funding Goals
TO PROVIDE SUPPORT FOR INITIATIVES FUNDED UNDER THE 21ST CENTURY CURES ACT TO SUPPORT CANCER RESEARCH, SUCH AS THE DEVELOPMENT OF CANCER VACCINES, THE DEVELOPMENT OF MORE SENSITIVE DIAGNOSTIC TESTS FOR CANCER, IMMUNOTHERAPY AND THE DEVELOPMENT OF COMBINATION THERAPIES, AND RESEARCH THAT HAS THE POTENTIAL TO TRANSFORM THE SCIENTIFIC FIELD, THAT HAS INHERENTLY HIGHER RISK, AND THAT SEEKS TO ADDRESS MAJOR CHALLENGES RELATED TO CANCER.
Grant Program (CFDA)
93.353 - 21st Century Cures Act - Beau Biden Cancer Moonshot
Awarding / Funding Agency
National Cancer Institute (NCI) [HHS - NIH]
Place of Performance
Washington United States
Geographic Scope
State-Wide
Related Opportunity
Fusion Oncoproteins in Childhood Cancers (FusOnC2) Consortium (U54 Clinical Trial Not Allowed) (RFA-CA-19-016)
Analysis Notes
Amendment Since initial award the End Date has been extended from 08/31/24 to 08/31/25 and the total obligations have increased 3% from $5,998,339 to $6,164,669.
Fred Hutchinson Cancer Center was awarded Biology and therapy of C11orf95-RELA fusion-driven ependymoma Cooperative Agreement U54CA243125 worth $6,164,669 from National Cancer Institute in September 2019 with work to be completed primarily in Washington United States. The grant has a duration of 6 years and was awarded through assistance program 93.353 21st Century Cures Act - Beau Biden Cancer Moonshot. The Cooperative Agreement was awarded through grant opportunity Fusion Oncoproteins in Childhood Cancers (FusOnC2) Consortium (U54 Clinical Trial Not Allowed).

Status
(Complete)

Last Modified 1/5/26

Period of Performance
9/19/19
Start Date
8/31/25
End Date
100% Complete

Funding Split
$6.2M
Federal Obligation
$0.0
Non-Federal Obligation
$6.2M
Total Obligated
100.0% Federal Funding
0.0% Non-Federal Funding

Activity Timeline

Interactive chart of timeline of amendments to U54CA243125

Subgrant Awards

Disclosed subgrants for U54CA243125

Transaction History

Modifications to U54CA243125

Additional Detail

Award ID FAIN
U54CA243125
SAI Number
U54CA243125-1174041595
Award ID URI
SAI UNAVAILABLE
Awardee Classifications
Nonprofit With 501(c)(3) IRS Status (Other Than An Institution Of Higher Education)
Awarding Office
75NC00 NIH National Cancer Institute
Funding Office
75NC00 NIH National Cancer Institute
Awardee UEI
TJFZLPP6NYL6
Awardee CAGE
50WB4
Performance District
WA-90
Senators
Maria Cantwell
Patty Murray

Budget Funding

Federal Account Budget Subfunction Object Class Total Percentage
National Cancer Institute, National Institutes of Health, Health and Human Services (075-0849) Health research and training Grants, subsidies, and contributions (41.0) $11,996,678 100%
Modified: 1/5/26